Adeline Lim

Radiation Oncologist. Views my own.

[Adeline Lim @adelinelim]

5th molecular class?! ER negative NSMPs associated with a poorer prognosis similar to p53 mutated endometrial cancers #ESMOGynae24 #gyncsm

[Australasian Brachytherapy Group @AusBrachy]

#ABG2024 Hobart @sylviahanna18 and colleagues representing @ONJCancerCentre novel techniques, brachy training, using MRI-sim. Exemplary work. @CarminiaLapuz @adelinelim

[Drew Moghanaki @DrewMoghanaki]

Published today: https://t.co/CIo3JQSgl6

[Shankar Siva @_ShankarSiva]

Dr Mercier late-breaking #ESTRO2023 - !!!BLINDED!!! RCT of #radiotherapy for painful bone Mets,
➡️single 8Gy 3DCRT versus SABR 20Gy. ⬆️ complete pain response 54% versus 33% at 3 months with SABR, but not 1 month. Higher rates of re-irradiation in conv RT arm. #radonc

[Matthias Guckenberger @Mat_Guc]

Safety analysis of Northstar trial: Phase II Randomized Study of Osimertinib With or Without Local Consolidative Therapy (LCT) for Metastatic EGFR Mutant NSCLC
👉 excellent safety of surgery & radiotherapy
👉 RT numerically lower tox despite no interruption of Osi in most pts

[Adeline Lim @adelinelim]

Excluding people with disabilities from becoming doctors “reductionist thinking that does a disservice to our profession”. What an impressive and eye-opening session. #racma2022

[RACMA @medManagerRACMA]

Dr Dinesh Palipana, Doctors With Disability says "we need to think about the communities we serve. 1 in 5 people have a disability. If we are doing the same thing we always have we are not going to go forward." RACMA 2022 - Equity and Access, Healthcare For All #racma2022

[Brendon Stiles @BrendonStilesMD]

Wow! Sublobar resection (including wedge) are equivalent to lobectomy for stage I lung cancer <2cm. No difference in DFS or OS and similar rates of recurrence. #WCLC22
Likely new standard of care!

[Adeline Lim @adelinelim]

Slowly getting there with regards to SRS for brain mets in patients with small cell lung cancer

[arjun sahgal @SahgalArjun]

Practice changing work led by @SunnyD_UT adding evidence to support SRS for small cell lung cancer brain mets. Congrats and thanks for building a great team and for @Sunnybrook to participate. https://t.co/xKocaX6lM5

[Corinne Faivre-Finn @finn_corinne]

Delighted to share our systematic review of heart dose
- More stringent IMRT❤️sparing planning objectives needed
- Consensus on contouring and Dose Volume Constraints is lacking
- Dose parameters reported for substructures vary substantially
https://t.co/P4Nu5fPWVX

[Adeline Lim @adelinelim]

Great study @leunger22 - would be a game changer. Am assuming you wouldn’t be doing this with concurrent chemo à la PORTEC-3, so patient population might end up being different to those in your study? #gyncsm

[Eric Leung @leunger22]

Can the number of radiation treatments to the pelvis for uterus cancer patients be decreased from 25 down to 5? See our recent publication in JAMA Oncology - The SPARTACUS trial. #radonc #GynCSM @Sunnybrook @LHSCCanada https://t.co/hgAczLGO1l

[Adeline Lim @adelinelim]

@MP_MacManus @SweetPingNg @UniMelb @PeterMacRadOnc @cd_fuller @gerryhanna Congratulations @SweetPingNg - what an amazing achievement and very well deserved!

[Adeline Lim @adelinelim]

Looking forward to this evening’s #TOGAsymp!

[Thoracic Oncology Group of Australasia @TOGAANZ]

Great to see our presenters gearing up. It's the middle of the night for Dr Bob Li but he looks pretty sprightly #TOGAsymp

[Adeline Lim @adelinelim]

Fascinating! #Brachytherapy in penile cancers #abg2022 #ThisisBrachytherapy #gucsm

[Adeline Lim @adelinelim]

Excellent dosimetry made possible by #3Dprinted applicators - could they be in our future @sylviahanna18 @CarminiaLapuz @NikkiShelton003? @ONJCancerCentre #gyncsm #ThisisBrachytherapy #abg002

[Carminia Lapuz @CarminiaLapuz]

Fascinating talk by @petric_primoz discussing #MR pre-planning for optimal gyn #brachy implant and #3Dprinting applications - innovations session #ABG22. @ausbrachy #gyncsm @sylviahanna18 @adelinelim @sylvia_vandyk

[Adeline Lim @adelinelim]

@sylvia_vandyk @sylviahanna18 @CarminiaLapuz @AusBrachy Amazing work for sure @sylviahanna18 !

[Stephen V Liu, MD @StephenVLiu]

Post-hoc analysis of immune-mediated adverse events with durvalumab from PACIFIC in @LungCaJournal. Usually occur in 1st 3m. Most common were pneumonitis and thyroid dysfunction. G3+ were uncommon. Reassuring report led by Dr. @DrJNaidoo et al. #LCSM

https://t.co/pVkCtbgYk0

[Adeline Lim @adelinelim]

Fascinating talk on brachytherapy for paediatric malignancies. Incredible work! #abg2022 #paediatricbrachy @AusBrachy @CarminiaLapuz @sylviahanna18 @sylvia_vandyk @drjchard @saratchanderRO @JPoderMedPhys

[Adeline Lim @adelinelim]

6 weekly source changes! #livingthedream #abg2022 #liverbrachy @stef_corradini @sylviahanna18 @CarminiaLapuz @sylvia_vandyk

[Adeline Lim @adelinelim]

So excited to attend this year’s Australian Brachytherapy Group’s ASM - very much looking forward to learning from the combined wealth of knowledge from the excellent speakers! @AusBrachy

[Sylvia Hanna @sylviahanna18]

3 days to go!!!
There is still time to register to what is promised to be an inspiring program.
Register now https://t.co/h7LOSNVeG6
@adelinelim @CarminiaLapuz @sylvia_vandyk @Elekta_ANZ @JPoderMedPhys @drjchard @andrejbece @AusBrachy @CathBeaufort @AmericanBrachy @ESTRO_RT

[Adeline Lim @adelinelim]

A fantastic opportunity to shape the future - and a great place to work!

[Nigel Anderson, PhD @RTAndersonNJ]

Are you a Radiation Therapist who’s passionate about research and helping others to do the same? Our newly established Senior Research Radiation Therapist role could be for you 👇 https://t.co/KW8PWH2PcN